Found: 19
Select item for more details and to access through your institution.
Microbiome and metabolomics in alcoholic liver disease.
- Published in:
- Clinical & Molecular Hepatology, 2022, v. 28, n. 3, p. 580, doi. 10.3350/cmh.2022.0171
- By:
- Publication type:
- Article
Effect of moderate-to-severe hepatic steatosis on neutralising antibody response among BNT162b2 and CoronaVac recipients.
- Published in:
- Clinical & Molecular Hepatology, 2022, v. 28, n. 3, p. 553, doi. 10.3350/cmh.2022.0082
- By:
- Publication type:
- Article
Clinical significance of the discrepancy between radiological findings and biochemical responses in atezolizumab plus bevacizumab for hepatocellular carcinoma.
- Published in:
- Clinical & Molecular Hepatology, 2022, v. 28, n. 3, p. 575, doi. 10.3350/cmh.2022.0047
- By:
- Publication type:
- Article
The effect of diabetes and prediabetes on the prevalence, complications and mortality in nonalcoholic fatty liver disease.
- Published in:
- Clinical & Molecular Hepatology, 2022, v. 28, n. 3, p. 565, doi. 10.3350/cmh.2022.0096
- By:
- Publication type:
- Article
Reappraisal of sepsis-3 and CLIF-SOFA as predictors of mortality in patients with cirrhosis and infection presenting to the emergency department: A multicenter study.
- Published in:
- Clinical & Molecular Hepatology, 2022, v. 28, n. 3, p. 540, doi. 10.3350/cmh.2021.0169
- By:
- Publication type:
- Article
Gut-derived lipopolysaccharide promotes alcoholic hepatosteatosis and subsequent hepatocellular carcinoma by stimulating neutrophil extracellular traps through toll-like receptor 4.
- Published in:
- Clinical & Molecular Hepatology, 2022, v. 28, n. 3, p. 522, doi. 10.3350/cmh.2022.0039
- By:
- Publication type:
- Article
Association of non-alcoholic fatty liver disease with incident dementia later in life among elder adults.
- Published in:
- Clinical & Molecular Hepatology, 2022, v. 28, n. 3, p. 510, doi. 10.3350/cmh.2021.0332
- By:
- Publication type:
- Article
Discovery of dipeptidyl peptidase-4 inhibitor specific biomarker in non-alcoholic fatty liver disease mouse models using modified basket trial.
- Published in:
- Clinical & Molecular Hepatology, 2022, v. 28, n. 3, p. 497, doi. 10.3350/cmh.2022.0019
- By:
- Publication type:
- Article
Therapeutic mechanisms and beneficial effects of non-antidiabetic drugs in chronic liver diseases.
- Published in:
- Clinical & Molecular Hepatology, 2022, v. 28, n. 3, p. 425, doi. 10.3350/cmh.2022.0186
- By:
- Publication type:
- Article
Association of nonalcoholic fatty liver disease with incident dementia later in life among elderly adults.
- Published in:
- Clinical & Molecular Hepatology, 2022, v. 28, n. 3, p. 481, doi. 10.3350/cmh.2022.0097
- By:
- Publication type:
- Article
A crystal ball to forecast treatment responsiveness in nonalcoholic fatty liver disease.
- Published in:
- Clinical & Molecular Hepatology, 2022, v. 28, n. 3, p. 478, doi. 10.3350/cmh.2022.0143
- By:
- Publication type:
- Article
Non-alcoholic fatty liver disease increases risk of carotid atherosclerosis and ischemic stroke: An updated meta-analysis with 135,602 individuals.
- Published in:
- Clinical & Molecular Hepatology, 2022, v. 28, n. 3, p. 483, doi. 10.3350/cmh.2021.0406
- By:
- Publication type:
- Article
RNA interference as a novel treatment strategy for chronic hepatitis B infection.
- Published in:
- Clinical & Molecular Hepatology, 2022, v. 28, n. 3, p. 408, doi. 10.3350/cmh.2022.0012
- By:
- Publication type:
- Article
Statin and aspirin for chemoprevention of hepatocellular carcinoma: Time to use or wait further?
- Published in:
- Clinical & Molecular Hepatology, 2022, v. 28, n. 3, p. 380, doi. 10.3350/cmh.2021.0366
- By:
- Publication type:
- Article
Does nonalcoholic fatty liver disease predispose patients to carotid arteriosclerosis and ischemic stroke?
- Published in:
- Clinical & Molecular Hepatology, 2022, v. 28, n. 3, p. 473, doi. 10.3350/cmh.2022.0155
- By:
- Publication type:
- Article
The best predictive model for hepatocellular carcinoma in patients with chronic hepatitis B infection.
- Published in:
- Clinical & Molecular Hepatology, 2022, v. 28, n. 3, p. 351, doi. 10.3350/cmh.2021.0281
- By:
- Publication type:
- Article
Crosstalk between tumor-associated macrophages and neighboring cells in hepatocellular carcinoma.
- Published in:
- Clinical & Molecular Hepatology, 2022, v. 28, n. 3, p. 333, doi. 10.3350/cmh.2021.0308
- By:
- Publication type:
- Article
Intrahepatic cholangiocarcinoma: Tumour heterogeneity and its clinical relevance.
- Published in:
- Clinical & Molecular Hepatology, 2022, v. 28, n. 3, p. 396, doi. 10.3350/cmh.2021.0287
- By:
- Publication type:
- Article
Imaging diagnosis of hepatocellular carcinoma: Future directions with special emphasis on hepatobiliary magnetic resonance imaging and contrast-enhanced ultrasound.
- Published in:
- Clinical & Molecular Hepatology, 2022, v. 28, n. 3, p. 362, doi. 10.3350/cmh.2021.0361
- By:
- Publication type:
- Article